Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1015518.RAt8mVO6CGTaKwuJd4qEzLSvRHHDcgNaLJZQ2tzMoaMFA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1015518.RAt8mVO6CGTaKwuJd4qEzLSvRHHDcgNaLJZQ2tzMoaMFA130_assertion type Assertion NP1015518.RAt8mVO6CGTaKwuJd4qEzLSvRHHDcgNaLJZQ2tzMoaMFA130_head.
- NP1015518.RAt8mVO6CGTaKwuJd4qEzLSvRHHDcgNaLJZQ2tzMoaMFA130_assertion description "[Herein, we show that in vivo administration of all-trans-retinoic acid (ATRA) or the histone deacetylase inhibitor sodium valproate (VPA) to patients affected with acute myeloid leukaemia (AML) M3 or M1 respectively, leads to the induction of transcription and expression of NKG2D-L at the surface of leukaemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1015518.RAt8mVO6CGTaKwuJd4qEzLSvRHHDcgNaLJZQ2tzMoaMFA130_provenance.
- NP1015518.RAt8mVO6CGTaKwuJd4qEzLSvRHHDcgNaLJZQ2tzMoaMFA130_assertion evidence source_evidence_literature NP1015518.RAt8mVO6CGTaKwuJd4qEzLSvRHHDcgNaLJZQ2tzMoaMFA130_provenance.
- NP1015518.RAt8mVO6CGTaKwuJd4qEzLSvRHHDcgNaLJZQ2tzMoaMFA130_assertion SIO_000772 19151770 NP1015518.RAt8mVO6CGTaKwuJd4qEzLSvRHHDcgNaLJZQ2tzMoaMFA130_provenance.
- NP1015518.RAt8mVO6CGTaKwuJd4qEzLSvRHHDcgNaLJZQ2tzMoaMFA130_assertion wasDerivedFrom befree-20150227 NP1015518.RAt8mVO6CGTaKwuJd4qEzLSvRHHDcgNaLJZQ2tzMoaMFA130_provenance.
- NP1015518.RAt8mVO6CGTaKwuJd4qEzLSvRHHDcgNaLJZQ2tzMoaMFA130_assertion wasGeneratedBy ECO_0000203 NP1015518.RAt8mVO6CGTaKwuJd4qEzLSvRHHDcgNaLJZQ2tzMoaMFA130_provenance.